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ABSTRACT 
Coronary artery disease, the main cause of heart disease, develops as immune cells and lipids accumulate into plaques 
within the coronary arterial wall. As a plaque grows, the tissue layer (fibrous cap) separating it from the blood flow 
becomes thinner and increasingly susceptible to rupturing and causing a potentially lethal thrombosis. The stabilization 
and/or treatment of atherosclerotic plaque is required to prevent rupturing and remains an unsolved medical problem. 
Here we show for the first time targeted, subsurface ablation of atherosclerotic plaque using ultrafast laser pulses. 
Excised atherosclerotic mouse aortas were ablated with ultrafast near-infrared (NIR) laser pulses. The physical damage 
was characterized with histological sections of the ablated atherosclerotic arteries from six different mice. The ultrafast 
ablation system was integrated with optical coherence tomography (OCT) imaging for plaque-specific targeting and 
monitoring of the resulting ablation volume. We find that ultrafast ablation of plaque just below the surface is possible 
without causing damage to the fibrous cap, which indicates the potential use of ultrafast ablation for subsurface 
atherosclerotic plaque removal. We further demonstrate ex vivo subsurface ablation of a plaque volume through a 
catheter device with the high-energy ultrafast pulse delivered via hollow-core photonic crystal fiber. 
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1. INTRODUCTION 
Heart disease is the most common cause of death worldwide, killing millions each year1. The main cause of heart 
disease, coronary artery disease, develops as immune cells and lipids accumulate into plaques within the wall of the 
coronary artery. As a plaque grows, the tissue layer (called the fibrous cap) separating it from the blood flow becomes 
thinner and increasingly susceptible to rupturing and causing a potentially lethal thrombosis2. When the fibrous cap 
becomes less than 65 m thick the plaque is considered unstable. The stabilization and/or treatment of unstable 
atherosclerotic plaque is required to prevent rupturing and remains a problematic medical condition out of the reach of 
existing plaque removal (atherectomy) devices. The laser atherectomy methods currently utilized are based on the 
ultraviolet excimer laser with nanosecond pulses. These lasers rely on linear absorption and thus are not fit for 
subsurface ablation3. Consequently, their use is limited to the extremities of the body where plaque rupture is less life 
threatening4 Here we demonstrate that ablation with ultrafast pulses (duration less than 10 ps) provides a mechanism to 
remove plaque without damaging the fibrous cap for prevention of plaque rupture during atherectomy. Subsurface 
ablation is enabled by the nonlinear absorption of the focused ultrafast pulse which confines the interaction to the focal 
volume5. Ultrafast ablation occurs when laser irradiance surpasses an optical breakdown threshold over which 
multiphoton ionization leads to plasma formation6. A cavitation bubble forms with the expansion of material vaporized 
during this process. The result is a highly confined ablation region and a lingering volume of gas that eventually diffuses 
into the surrounding tissue7.  
In this paper, we demonstrate targeted, ultrafast ablation of atherosclerotic plaques in free space and, for the first 
time, through a fiber-based catheter. We describe the results of an ex vivo investigation of the surface damage caused by 
ultrafast ablation in atherosclerotic plaque of a mice model. Furthermore, we monitor the ablation using optical 
coherence tomography (OCT), an imaging modality commonly used to characterize atherosclerotic plaques8. We find 
that ultrafast ablation of plaque just below the surface is possible without causing damage to the fibrous cap via our 
catheter prototype, which indicates the potential use of ultrafast ablation for subsurface atherosclerotic plaque removal. 
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2. EXPERIMENTAL METHODS 
The ablation experiments were performed on aortas extracted from genetically engineered mice lacking the 
apolipoprotein E (ApoE) gene9. The ApoE knock-out (ApoE-KO) mice developed atherosclerotic plaques within the 
tunica intima just a few microns below the endothelium of the arterial wall and grew to a couple hundred microns thick 
after being fed a lipid-rich diet. The plaques have a similar composition to human plaque with a fatty deposit and a thin 
fibrous cap10. Six animals were fed a lipid rich diet (0.2% cholesterol and 21% butter, Western U8958 version 35, SAFE, 
France) for 12 to 16 weeks. The mice were anesthetized and sacrificed prior to aorta harvesting. After harvesting the 
aortas were kept in phosphate buffer saline (PBS) solution on ice for 2 to 5 hours, afterwards the arteries were cut open 
along the longitudinal axis and mounted on a microscope slide in PBS solution with a cover slide. The tissues were then 
subjected to laser ablation with illumination from the endothelial side. All animals received humane care in compliance 
with the European Convention on Animal Care and in accordance with the Swiss Animal Protection Law after obtained 
permission of the State Veterinary Office, approved by the Swiss Federal Veterinary Office, Switzerland (FR 2013/35).  
 
Figure 1. Schematics of the ablation setups. (a) The ablation setup for subsurface ablation analysis and OCT 
visualization.  (b) The prototype catheter probe ablation setup. 
Optical systems were built to facilitate the subsurface ultrafast ablation analysis (Figure 1(a)) and for initial ablation 
tests with a catheter probe prototype (Figure 1(b)). A beam from a 1030nm fiber laser (Satsuma HP2, Amplitude 
Systèmes) with tunable pulse width, repetition rate, and pulse energy provided high-energy, ultrafast laser input to the 
system. A 1.5 ps pulse duration, was selected to lessen nonlinear self-focusing effects11 while having ablation threshold 
values similar to femtosecond pulses12. With the repetition rate set at 1 kHz, pulse to pulse heat accumulation was 
avoided13. For the subsurface ablation analysis the beam was collimated and expanded to fill the back aperture of a water 
immersion, long working distance objective (NA 0.8, providing FWHM focus spot of 0.8 m transverse and 1 m axial) 
mounted in an upright position. The objective focused the beam on the sample, which was mounted on a 3-axis piezo 
mechanical stage. To monitor the target area two imaging systems were integrated into the system: (1) a CCD camera 
provided a widefield image of the target area via a removable beamsplitter and (2) a spectral domain OCT system 
(Thorlabs, Ganymede) observed the same sample area from the posterior side. The OCT enabled depth-resolved 
visualization of the ablated tissue. For the prototype catheter setup (Figure 1(b)), the beam was coupled into an optical 
fiber for delivery to the catheter probe which is described in Section 5. The laser parameters, the stage motion, and both 











To facilitate subsurface ablation analysis, a specific ablation pattern was implemented by movement of the 
mechanical stage. The stage speed was adjusted to v = (1 – n)df , where d is the FWHM of the focused laser spot, f is the 
laser pulse repetition rate, and n is the percentage overlap between subsequent pulses (set between 0 and 0.8). The 
pattern created either 8 or 10 ablation lines, with each line separated in the transverse (x) direction by įx = 30 m and in 
the axial (z) direction by įz = 10 m or įz = 15 m. The number of lines and įz were selected to allow for ablation 
through the entire artery.  
To preserve the ablation holes for analysis, the ablated tissue samples were frozen and prepared for histologic 
sectioning. To ensure measurement of ablation hole size and not gas bubble size, a time greater than the observed gas 
bubble diffusion time (~30 min) elapsed following the ablation. The samples were then removed from the slide and 
immersed into cryogenic matrix (Cryomatrix, Thermo Scientific) and slowly frozen to -20°C in the fumes of isopentane 
cooled by dry ice. Later, the samples were cut orthogonal to the ablation lines into 8 m sections using a cryocut and 
stained with haematoxylin and eosin (H&E) for analysis of the ablated tissue. 
3. SUBSURFACE ABLATION ANALYSIS 
We analyzed the dependence of surface damage risk on pulse energy and ablation depth in plaque. The H&E stained 
histological sections were evaluated under a transmission widefield microscope with a 40x objective (NA 0.7). The 
existence of surface damage was determined based on whether any structural modification existed above an ablation hole 
and near the surface of the tissue sample (<10 m). This damage was observed by visual inspection of the histological 
section as a structural deformation near the artery endothelium. For example, Figure 2(a) shows a row of ablation holes 
which move from deeper to shallower ablation depth from left to right. The first three holes from the left show no signs 
of surface damage, whereas the right-most hole shows a structural modification of the tissue near the surface. Figure 2(b) 
plots the percentage of ablation holes with surface damage as a function of pulse energy and depth of 1075 observed 
holes. As expected, the likelihood of surface damage decreases with increasing depth and decreasing energy. The results 
indicate that the risk of surface damage is minimal (around 5%) when focusing deeper than 20 m under the surface with 
pulse energies below 2 J. Importantly, this suggests the possibility of ablating vulnerable plaques without damaging 
thin fibrous caps.  
 
Figure 2. (a) A representative sample of ablated arterial tissue. (b) The percentage of ablation holes with surface 
damage as a function of pulse energy and depth. 
4. OCT OBSERVATION OF SUBSURFACE ABLATION 
The high refractive index difference between tissue and the vapor bubble resulting from ablation is well suited for 
OCT imaging. In the case of atherosclerotic plaque, OCT can be used to both locate the plaque and monitor the ablation. 
An initial test to image bulk subsurface ablation with OCT in a non-atherosclerotic mouse aorta (obtained from a 
C57/BL/6 mouse) was pursued. For bulk material ablation, a pattern was implemented to ablate a single plane of area 











two different locations. An OCT image acquired a few seconds after ablation showed two 30 m thick, gas filled 
volumes in the scanned area (Figure 3(a)). The sample was then frozen, sectioned, and stained with H&E following the 
method described previously (Figure 3(b)). The ablation area appears clearly defined in the histological section without 
detectable structural damage near the surface. In general there is excellent agreement between the OCT and histology 
images where both show a pair of clearly defined ablation volumes. 
 
Figure 3. Tunica media of non-atherosclerotic mouse aorta ablated with a 100x200 m2 planes. (a) Transverse OCT 
image of the ablation area. (b) Transverse histological cut of the ablation area. A and B mark the two different areas of 
ablation. The images are oriented in the same direction. The incident ablation pulse comes from the endothelium side. 
The scale bars are 100 m. 
5. PROTOTYPE CATHETER PROBE 
The applicability of ultrafast ablation of atherosclerotic plaque depends on the ability to transfer the laser pulses through 
optical fibers to a catheter device. Fortunately, in the last decade there has been consistent progress in the maximum 
peak power which can propagate through single-mode hollow core photonic crystal fibers (HC-PCF)14. To demonstrate 
this capability, we built a prototype catheter probe to test subsurface ablation of plaque with light delivery through a HC-
PCF (Figure 4(a)). The 1.2 mm diameter probe houses the distal end of a single cell Kagome HC-PCF, for light delivery, 
with a lens (LightPath Technologies, 355070) to focus the light at a moderately high NA (0.6) into ApoE-KO plaque. 
For this initial demonstration the tissue sample was placed on the translation stage, while the catheter probe was 
stationary (Figure 1(b)). The tissue was scanned to target a 50 m deep, 70x70 m2 plane. Following ablation the sample 
was prepared for histological sectioning following the method described previously.  Figure 4(b) shows the H&E stained 
slice of ablated tissue. The 70 m range of ablated plaque is visible below the red line. Further development of the 












Figure 4. (a) Prototype catheter probe used to test ablation. (b) Subsurface ablation of plaque with the prototype catheter probe 
6. DISCUSSION 
We have analyzed subsurface ultrafast ablation in atherosclerotic plaque and tunica media tissue. We also demonstrated 
OCT imaging of the ablated volume which provided high contrast images of the gas bubble resulting from ablation. The 
use of OCT in conjunction with plaque ablation is convenient because IV-OCT devices already provide clinicians a 
high-resolution tool for plaque recognition and characterization15. The results showed that pulse energies below 4 J 
provided axially isolated ablation volumes, such that ablation targeted deeper than 20 m rarely caused surface damage. 
These results suggest the possibility of the fine ablation of unstable plaques only a few tens of microns beneath the 
endothelium. We have also presented the initial subsurface plaque ablation results from a catheter probe. 
To better understand the effects of ultrafast ablation on plaque several experiments should be pursued. A study of the 
collateral cellular damage and reaction to ultrafast ablation would be informative because cell damage or death can 
extend beyond the ablation volume16. An experiment to examine the effects of ultrafast ablation on various plaque 
compositions should also be pursued. Also, investigating the long-term effects, such as inflammation and other immune 
responses, is necessary to understanding the medical implications of this approach. Of course, this study would require in 
vivo testing for which a further developed catheter prototype would be appropriate.  
7. CONCLUSION 
We have presented the initial steps towards the use of ultrafast ablation for atherosclerotic plaque treatment. We have 
characterized ultrafast ablation in atherosclerotic plaque performed on the atherosclerotic aortas of ApoE-KO mice. OCT 
provided high contrast images of the gas bubble resulting from ablation. The results indicate that pulse energies below 2 
J provide axially isolated ablation volumes, within the range of energy of our initial catheter prototype, such that 
ablation targeted deeper than 20 m rarely induce surface damage. These results suggest the possibility of the fine 
ablation of unstable plaques while preserving the stabilizing fibrous cap.  
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